Best Prescription Sleep Medications Available Online in the UK

Persistent insomnia can affect far more than your nights.

Regularly struggling to fall asleep, waking repeatedly or lying awake for hours can eventually affect concentration, mood, productivity, relationships and overall quality of life.

For people living with significant sleep problems, prescription treatment may sometimes be appropriate. However, there is no single “best sleeping tablet” for everyone.

Different prescription sleep medications available in the UK have different purposes. Some are designed primarily for short-term insomnia, while newer treatments such as QUVIVIQ▼ (daridorexant) are specifically licensed for adults with chronic insomnia lasting at least three months where daytime functioning is considerably affected.

The right treatment depends on:

• how long you have had insomnia;

• whether you struggle to fall asleep, remain asleep or both;

• the effect on your daytime functioning;

• your medical history;

• other medicines you take;

• whether CBT for insomnia has already been tried;

• and the potential risks and benefits of medication.

In this guide, we compare some of the main prescription insomnia treatments used in the UK, explain how they work and discuss how 24 HR Pharmacy can help eligible adults access clinically appropriate treatment online.

What Counts as Chronic Insomnia?

Everyone experiences occasional poor sleep.

A stressful week at work, illness, travel, bereavement, relationship problems or a disrupted routine can all temporarily affect sleep.

Chronic insomnia is different.

It involves persistent problems such as:

• difficulty falling asleep;

• repeatedly waking during the night;

• finding it difficult to return to sleep;

• waking much earlier than intended;

• or getting sleep that does not feel restorative.

For treatments such as QUVIVIQ▼, chronic insomnia means symptoms have been present for at least three months and are having a considerable effect on daytime functioning.

That daytime effect may include:

• excessive tiredness;

• difficulty concentrating;

• reduced productivity;

• poor memory;

• irritability;

• low motivation;

• difficulty coping with everyday responsibilities;

• and reduced quality of life.

This distinction matters because treatment for occasional insomnia is not necessarily the same as treatment for persistent chronic insomnia.

Should Prescription Sleeping Tablets Be the First Treatment?

Not necessarily.

For chronic insomnia, cognitive behavioural therapy for insomnia (CBTi) plays an important role.

CBTi aims to identify and change thoughts and behaviours that maintain insomnia rather than simply causing temporary sedation.

It can involve:

• establishing more consistent sleep and waking times;

• reducing time spent awake in bed;

• improving the association between bed and sleep;

• reducing anxiety about bedtime;

• challenging unhelpful beliefs about sleep;

• and addressing habits such as excessive clock-watching.

Current NICE guidance positions QUVIVIQ▼ for adults with chronic insomnia where CBTi has already been tried without enough improvement, or where CBTi is unavailable or unsuitable.

Medication therefore forms part of a wider clinical pathway rather than automatically being the first answer to every sleep problem.

What Prescription Sleep Medications Are Available in the UK?

Different types of medicine may be prescribed depending on the circumstances.

Important categories include:

• dual orexin receptor antagonists, such as QUVIVIQ▼;

• Z-drugs, such as zopiclone and zolpidem;

• certain benzodiazepines for severe short-term insomnia;

• and other medicines used where another medical or psychological condition is contributing to poor sleep.

Each group works differently and has a different balance of benefits and risks.

QUVIVIQ▼ (Daridorexant): A Newer Treatment for Chronic Insomnia

QUVIVIQ▼ contains the active ingredient daridorexant.

It belongs to a newer class of medicines known as dual orexin receptor antagonists.

How does QUVIVIQ▼ work?

Orexin is a naturally occurring chemical messenger in the brain that promotes wakefulness.

Daridorexant blocks orexin receptors, reducing this wake-promoting signal at night.

Rather than broadly sedating the brain through the same pathway as older sleeping medicines, QUVIVIQ▼ targets part of the system responsible for keeping you awake.

It is designed to help:

• reduce the time it takes to fall asleep;

• improve the ability to stay asleep;

• reduce waking during the night;

• and improve daytime functioning.

This different mechanism is one of the main reasons QUVIVIQ▼ has become an important new option for chronic insomnia.

Who Is QUVIVIQ▼ Intended For?

QUVIVIQ▼ is licensed for adults with insomnia where:

• symptoms have lasted for at least three months;

• sleep problems are considerably affecting daytime functioning;

• and treatment is clinically appropriate following assessment.

Under current NICE guidance, it should generally be considered where CBTi has already been tried without adequate improvement or where CBTi is unavailable or unsuitable.

It is therefore not intended simply for an occasional bad night's sleep.

QUVIVIQ▼ Dosage

QUVIVIQ▼ is available in two strengths:

• 25 mg

• 50 mg

The usual recommended dose is:

50 mg once nightly.

The tablet should be taken:

• once per evening;

• within approximately 30 minutes before going to bed;

• and only when you are able to allow sufficient time for sleep.

The maximum daily dose is 50 mg.

When might 25 mg be prescribed?

A lower 25 mg dose may be appropriate in some patients, including those with:

• moderate hepatic impairment;

• certain moderate CYP3A4 inhibitor medicines;

• use of other central nervous system depressants;

• or other circumstances where the prescriber considers a lower dose appropriate.

The decision between 25 mg and 50 mg must be made by a qualified healthcare professional.

What If You Forget QUVIVIQ▼?

If you forget the tablet at bedtime, do not take it later during the night.

Wait until the next scheduled evening dose.

Taking it late could increase the likelihood of next-day impairment or excessive sleepiness.

Can You Drive After Taking QUVIVIQ▼?

Because QUVIVIQ▼ reduces wakefulness, it may affect driving and other activities requiring concentration.

Patients should allow approximately nine hours between taking QUVIVIQ▼ and driving or operating machinery, particularly during the first few days of treatment.

Even after nine hours, you should only drive if you feel completely alert.

Do not drive if you feel:

• sleepy;

• dizzy;

• confused;

• unusually fatigued;

• or unable to concentrate normally.

QUVIVIQ▼ and Alcohol

Alcohol should be avoided while taking QUVIVIQ▼.

Combining alcohol with a sleep medicine may increase:

• drowsiness;

• impaired coordination;

• delayed reaction times;

• and reduced alertness.

Patients taking QUVIVIQ▼ should also avoid grapefruit or grapefruit juice in the evening because of the potential effect on how the medicine is metabolised.

QUVIVIQ▼ Side Effects

Like all medicines, QUVIVIQ▼ can cause side effects.

Common side effects

These may include:

• headache;

• sleepiness or drowsiness;

• dizziness;

• nausea;

• and fatigue.

Next-day drowsiness may be more noticeable during the first few days while the body adjusts.

Uncommon side effects

These may include:

• sleep paralysis;

• hallucinations;

• and vivid or unusual perceptions while falling asleep or waking.

Sleep paralysis refers to a temporary inability to move or speak during the transition between sleep and wakefulness.

Speak to your prescriber if you develop troublesome or unusual symptoms.

Advantages of QUVIVIQ▼

Potential advantages include:

• specifically licensed for chronic insomnia;

• a different mechanism from traditional Z-drugs and benzodiazepines;

• once-nightly dosing;

• ability to target both falling asleep and staying asleep;

• potential improvement in daytime functioning;

• and suitability for longer-term clinical management than medicines normally restricted to only a few weeks, where ongoing treatment remains appropriate.

Treatment should still be reviewed regularly and continued only when the benefits remain worthwhile.

Potential Disadvantages of QUVIVIQ▼

QUVIVIQ▼ is not appropriate for everyone.

Potential disadvantages and limitations include:

• possible next-day drowsiness;

• dizziness and fatigue;

• medicine interactions;

• the need to avoid alcohol;

• uncommon sleep paralysis or hallucinations;

• caution in patients with certain psychiatric or respiratory conditions;

• and ongoing clinical monitoring.

It is also contraindicated in people with narcolepsy and those taking certain strong CYP3A4 inhibitors.

Which Prescription Sleep Medication Is Best for Chronic Insomnia?

For chronic insomnia, the treatment pathway is different from short-term sleeplessness.

CBTi should generally be considered first.

For adults who:

• have had insomnia for three months or longer;

• experience considerable daytime impairment;

• and have already tried CBTi without enough improvement, or cannot access or use CBTi;

QUVIVIQ▼ may be an appropriate prescription option, subject to clinical assessment.

This is different from zopiclone and zolpidem, which have traditionally been used primarily for short-term insomnia.

Which Medication Is Best for Short-Term Insomnia?

For severe short-term insomnia, a clinician may occasionally consider medication such as zopiclone or zolpidem.

The aim is usually to provide temporary relief during an acute period rather than establish indefinite nightly treatment.

The decision will depend on factors including:

• the severity of the insomnia;

• how recently it began;

• the underlying cause;

• age;

• fall risk;

• other medicines;

• alcohol use;

• breathing disorders;

• and previous sedative use.

Which Treatment Is Best If You Struggle to Fall Asleep?

Difficulty falling asleep is known as sleep-onset insomnia.

Potential contributors include:

• anxiety;

• stress;

• excessive caffeine;

• irregular sleep routines;

• spending too much time in bed;

• and anxiety about not sleeping.

The appropriate treatment depends on the underlying pattern and duration rather than simply choosing whichever medicine acts fastest.

QUVIVIQ▼ has been designed to help reduce the time taken to fall asleep while also supporting sleep maintenance in people with chronic insomnia.

What If You Keep Waking During the Night?

This is often called sleep-maintenance insomnia.

Possible causes include:

• chronic insomnia;

• obstructive sleep apnoea;

• alcohol use;

• menopause;

• chronic pain;

• acid reflux;

• urinary problems;

• restless legs syndrome;

• and medicine side effects.

Repeated waking should therefore be assessed before treatment is selected.

A sedative tablet may not address the underlying cause.

Sleep Apnoea Can Look Like Insomnia

Not everyone repeatedly waking at night has primary insomnia.

Obstructive sleep apnoea can cause:

• repeated nighttime waking;

• loud snoring;

• choking or gasping;

• pauses in breathing;

• morning headaches;

• dry mouth;

• and severe daytime sleepiness.

If these symptoms are present, an assessment for sleep apnoea may be more appropriate than immediately prescribing sleeping tablets.

Restless Legs Syndrome

Another potential cause of poor sleep is restless legs syndrome.

Typical symptoms include:

• an uncomfortable feeling in the legs;

• an overwhelming need to move them;

• symptoms that become worse while resting;

• and temporary relief after moving.

Treating the underlying problem may be more effective than using a general sleep medicine.

Menopause and Insomnia

Sleep problems are particularly common during perimenopause and menopause.

Hot flushes, night sweats, anxiety and hormonal changes can all contribute to repeated waking.

Treatment may involve addressing menopause symptoms as well as insomnia.

A healthcare professional can help determine whether the primary problem is chronic insomnia, menopausal symptoms or a combination of both.

Can Prescription Sleep Medication Cause Dependence?

Some medicines carry a greater dependence risk than others.

Z-drugs and benzodiazepines can cause:

• tolerance;

• physical dependence;

• psychological reliance;

• withdrawal;

• and rebound insomnia.

This is one reason they are normally reserved for short-term treatment.

QUVIVIQ▼ acts through a different biological pathway, but it is still a prescription medicine that must be used responsibly and reviewed regularly.

Patients with a history of alcohol or substance misuse require particular caution.

Is It Safe to Buy Sleeping Tablets Online?

The important distinction is between accessing treatment through a regulated online pharmacy and purchasing tablets from an unregulated website or social-media seller.

Legitimate prescription insomnia treatment requires:

• an appropriate consultation;

• review of your medical history;

• assessment of current medicines;

• screening for contraindications;

• a prescription from an authorised prescriber;

• and dispensing through a regulated pharmacy.

You should avoid websites selling prescription sleeping tablets without any meaningful clinical assessment.

Medicines obtained from unregulated sources may be:

• counterfeit;

• incorrectly dosed;

• contaminated;

• or unsuitable for your medical circumstances.

What Should an Online Insomnia Assessment Check?

Before prescribing treatment, a healthcare professional may need to know:

• how long you have had sleep problems;

• whether you struggle to fall asleep, remain asleep or both;

• how frequently symptoms occur;

• the impact on your daytime functioning;

• whether you have tried CBTi;

• your current medicines;

• your physical health;

• your mental health;

• alcohol and substance use;

• liver problems;

• pregnancy or breastfeeding;

• and whether symptoms could suggest another sleep disorder.

This is why reputable online prescribing is more than filling in a few details and ordering a tablet.

Who Should Not Take QUVIVIQ▼?

QUVIVIQ▼ is not suitable for people who:

• are allergic to daridorexant or another ingredient;

• have narcolepsy;

• or are taking certain strong CYP3A4 inhibitor medicines.

Extra caution may also be required in people who:

• have moderate hepatic impairment;

• take other CNS-depressant medicines;

• are elderly, particularly over 75;

• have symptoms of depression;

• have psychiatric co-morbidities;

• have severe COPD;

• have a history of alcohol or substance misuse;

• are pregnant;

• or are breastfeeding.

A qualified prescriber must consider these factors before issuing treatment.

How Long Can You Take Prescription Sleep Medication?

This depends heavily on the medication.

Z-drugs

Zopiclone and zolpidem are generally intended for short periods because tolerance and dependence can develop.

QUVIVIQ▼

QUVIVIQ▼ follows a different treatment model.

Treatment should still be kept as short as clinically appropriate, but suitability is reassessed within three months of starting and periodically thereafter.

If the medicine has not worked adequately or is no longer appropriate, treatment should be stopped.

Regular review is therefore an essential part of safe chronic insomnia treatment.

How 24 HR Pharmacy Can Help

At 24 HR Pharmacy, the aim is not to simply sell sleeping tablets online.

The insomnia service is designed to help eligible adults access appropriate treatment after a structured clinical assessment.

For chronic insomnia, this may include consideration of QUVIVIQ▼ (daridorexant).

1. Complete an Online Assessment

You begin by completing a confidential questionnaire covering:

• how long your insomnia has lasted;

• how frequently it occurs;

• whether you struggle to fall asleep or remain asleep;

• the effect on daytime life;

• previous insomnia treatment;

• whether CBTi has been tried;

• your medical history;

• current medicines;

• mental health;

• and other relevant risk factors.

2. Clinical Review by a UK-Registered Prescriber

A qualified prescriber then reviews the information to determine whether prescription treatment is appropriate.

This includes checking for:

• contraindications;

• interacting medicines;

• narcolepsy;

• possible sleep apnoea;

• liver impairment;

• mental health concerns;

• alcohol or substance misuse;

• and other conditions requiring a different treatment pathway.

3. Individualised Treatment

Where QUVIVIQ▼ is considered clinically appropriate, the prescriber determines the correct dose.

The usual adult dose is:

50 mg once nightly within approximately 30 minutes before bed.

A lower 25 mg once-nightly dose may be selected for certain patients based on their medical history, liver function, interacting medicines or use of other CNS depressants.

The maximum daily dose is 50 mg.

4. Regulated Dispensing

If approved, the prescription is dispensed through a regulated pharmacy.

Patients receive the appropriate medicine and patient information rather than purchasing unknown products from an unregulated supplier.

5. Discreet UK Delivery

Approved treatment can be sent directly to your chosen address in discreet packaging.

6. Ongoing Clinical Support

Prescription insomnia treatment should not be issued and forgotten.

24 HR Pharmacy can support ongoing reviews to assess:

• whether your sleep has improved;

• whether daytime functioning has improved;

• whether you are experiencing side effects;

• whether new medicines affect treatment;

• and whether continuing QUVIVIQ▼ remains appropriate.

With QUVIVIQ▼, suitability should be reassessed within three months of starting treatment and periodically afterwards.

Frequently Asked Questions

What is the best prescription sleeping tablet in the UK?

There is no single best treatment.

The appropriate medicine depends on whether insomnia is short-term or chronic, the underlying cause, other medicines and your individual medical history.

For chronic insomnia lasting three months or more where CBTi has not worked or is unavailable or unsuitable, QUVIVIQ▼ may be considered.

What is the best prescription medication for chronic insomnia?

CBTi remains an important first-line treatment.

Where CBTi has been unsuccessful, unavailable or unsuitable and insomnia is significantly affecting daytime life, QUVIVIQ▼ is a licensed treatment option for eligible adults.

Is QUVIVIQ▼ a sleeping tablet?

Yes. QUVIVIQ▼ is a prescription insomnia medicine containing daridorexant.

However, it works differently from traditional Z-drugs and benzodiazepines by blocking the orexin wakefulness pathway.

What is the normal dose of QUVIVIQ▼?

The usual recommended dose is 50 mg once nightly, taken within approximately 30 minutes before going to bed.

A 25 mg dose may be used in certain patients.

Is QUVIVIQ▼ better than zopiclone?

They have different roles.

Zopiclone is generally used for short-term severe insomnia, while QUVIVIQ▼ is licensed for chronic insomnia lasting at least three months with significant daytime impairment.

The appropriate choice depends on your circumstances rather than one medicine being universally “better”.

Is QUVIVIQ▼ addictive?

QUVIVIQ▼ has a different mechanism and dependence profile from older Z-drugs and benzodiazepines, but it is still a prescription medicine and requires clinical monitoring.

Extra caution is appropriate in people with a history of alcohol or substance misuse.

Can I buy QUVIVIQ▼ online in the UK?

Because QUVIVIQ▼ is prescription-only, it should only be supplied following an appropriate clinical assessment.

Through 24 HR Pharmacy, eligible adults can complete an online assessment that is reviewed by a qualified UK prescriber before treatment is approved.

Can I buy zopiclone online legally?

Prescription-only sleeping tablets should only be supplied through a regulated pharmacy following an appropriate prescription.

Avoid websites selling zopiclone or other controlled or prescription medicines without a legitimate consultation and prescription.

Can I drink alcohol with prescription sleeping medication?

Alcohol should generally be avoided because it can increase sedation and impairment.

Alcohol should specifically be avoided with QUVIVIQ▼.

How soon before bed should I take QUVIVIQ▼?

Take it in the evening within approximately 30 minutes before going to bed.

What happens if I forget QUVIVIQ▼?

Do not take the forgotten tablet later in the night. Wait until your next scheduled dose.

Final Thoughts

The best prescription sleep medication available online in the UK is not necessarily the strongest or fastest-acting tablet.

The best treatment is the one that appropriately matches the cause, duration and severity of your insomnia while providing an acceptable balance of benefits and risks.

Traditional treatments such as zopiclone and zolpidem can provide short-term relief in selected cases, but their risks of tolerance and dependence mean they are usually unsuitable as indefinite treatments for chronic insomnia.

For adults experiencing chronic insomnia lasting at least three months, where daytime functioning is considerably affected and CBTi has not worked or is unavailable or unsuitable, QUVIVIQ▼ (daridorexant) offers a newer treatment option.

Its mechanism is different from traditional sedative sleeping tablets. By blocking orexin receptors, QUVIVIQ▼ reduces part of the brain's wakefulness signalling rather than primarily enhancing the GABA system.

The usual dose is 50 mg once nightly, with 25 mg used in certain clinical circumstances. Treatment requires careful screening, correct dosing and ongoing clinical review.

Through its online insomnia service, 24 HR Pharmacy can help eligible adults complete a confidential consultation, have their symptoms and medical history reviewed by a UK-registered prescriber and access appropriate prescription treatment where it is safe to do so.

The goal should not simply be to find a tablet that makes you sleepy.

It should be to identify the cause of your insomnia and find a safe, sustainable treatment that improves both your sleep and your ability to function during the day.